This psychedelic therapy FAQ compiles the most common and most important questions from people seriously considering psilocybin or other psychedelic-assisted approaches. The answers here are grounded in current clinical research, verified legal data, and practical...
Ketamine vs. esketamine (Spravato) is one of the most common points of confusion for people exploring treatment-resistant depression options. Both work through a similar mechanism in the brain, but they differ in molecular composition, route of administration, FDA...
Last Updated: May 2026 Psychedelic therapy Ohio residents can legally access today means ketamine. Psilocybin remains a Schedule I substance in Ohio, West Virginia, and under federal law. Vermont is further along than most states in its policy process, but no legal...
Talking to your doctor about psychedelic therapy is one of the most common points where people get stuck. This guide walks you through how to frame the conversation, what questions to bring, and what to understand about medications like SSRIs before you book that...
Last Updated: May 2026 Psychedelic therapy Georgia seekers can access today is primarily ketamine-based, with FDA-cleared options available in Atlanta, Nashville, and Asheville. Psilocybin remains a Schedule I substance across Georgia, Tennessee, North Carolina, and...
Psychedelic therapy in Pennsylvania is at an early but real stage of development. Ketamine is the only legally available psychedelic-assisted treatment within the state right now, with established clinics in both Philadelphia and Pittsburgh. Psilocybin therapy is not...
